Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000322767 | SCV000365588 | uncertain significance | Myofibrillar myopathy 4 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000379731 | SCV000365589 | uncertain significance | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000287151 | SCV000365590 | uncertain significance | Left ventricular noncompaction cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000342117 | SCV000365591 | uncertain significance | Myofibrillar Myopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000600251 | SCV000728645 | likely benign | not specified | 2017-03-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000322767 | SCV004697171 | likely benign | Myofibrillar myopathy 4 | 2023-12-30 | criteria provided, single submitter | clinical testing |